BALTIMORE (WJZ) — A potentially game-changing drug in the fight against COVID-19.

Pharmaceutical company Merck and Ridgeback Biotherapeutics said they’ve developed a drug that reduces the risk of hospitalization or death for patients with mild or moderate cases of COVID.

Read more